Role of Creatine in the Heart: Health and Disease
Open Access
- 7 April 2021
- Vol. 13 (4), 1215
- https://doi.org/10.3390/nu13041215
Abstract
Creatine is a key player in heart contraction and energy metabolism. Creatine supplementation (throughout the paper, only supplementation with creatine monohydrate will be reviewed, as this is by far the most used and best-known way of supplementing creatine) increases creatine content even in the normal heart, and it is generally safe. In heart failure, creatine and phosphocreatine decrease because of decreased expression of the creatine transporter, and because phosphocreatine degrades to prevent adenosine triphosphate (ATP) exhaustion. This causes decreased contractility reserve of the myocardium and correlates with left ventricular ejection fraction, and it is a predictor of mortality. Thus, there is a strong rationale to supplement with creatine the failing heart. Pending additional trials, creatine supplementation in heart failure may be useful given data showing its effectiveness (1) against specific parameters of heart failure, and (2) against the decrease in muscle strength and endurance of heart failure patients. In heart ischemia, the majority of trials used phosphocreatine, whose mechanism of action is mostly unrelated to changes in the ergogenic creatine-phosphocreatine system. Nevertheless, preliminary data with creatine supplementation are encouraging, and warrant additional studies. Prevention of cardiac toxicity of the chemotherapy compounds anthracyclines is a novel field where creatine supplementation may also be useful. Creatine effectiveness in this case may be because anthracyclines reduce expression of the creatine transporter, and because of the pleiotropic antioxidant properties of creatine. Moreover, creatine may also reduce concomitant muscle damage by anthracyclines.Keywords
Funding Information
- Ministero della Salute (Ricerca Corrente)
- AlzChem Trostberg GmbH (It paid article processing charges)
This publication has 103 references indexed in Scilit:
- Creatine Kinase-Overexpression Improves Myocardial Energetics, Contractile Dysfunction and Survival in Murine Doxorubicin CardiotoxicityPLOS ONE, 2013
- Ribose Supplementation Alone or with Elevated Creatine Does Not Preserve High Energy Nucleotides or Cardiac Function in the Failing Mouse HeartPLOS ONE, 2013
- Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarctionCardiovascular Research, 2012
- Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective EffectsPLOS ONE, 2012
- Creatine but not betaine supplementation increases muscle phosphorylcreatine content and strength performanceAmino Acids, 2011
- The creatine kinase system and pleiotropic effects of creatineAmino Acids, 2011
- The creatine kinase reaction: a simple reaction with functional complexityAmino Acids, 2011
- Changes in creatine transporter function during cardiac maturation in the ratBMC Developmental Biology, 2010
- Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacityJournal of Molecular and Cellular Cardiology, 2009
- Adriamycin-induced oxidative mitochondrial cardiotoxicityCell Biology and Toxicology, 2006